*: Hormone therapy is in addition to lifestyle and behavior interventions to prevent and treat concomitant hypertension, insulin resistance, type 2 diabetes mellitus, dyslipidemia, and obesity: preferably to start early in the perimenopause; rule out contraindications (see main text); must be individualized. IUCD: intrauterine contraceptive device.
Declarations
Author contributions
NG, LG, and SRG: Conceptualization, Writing—original draft, Writing—review & editing. All authors read and approved the submitted version.
Conflicts of interest
The authors declare that they have no conflicts of interest.
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.
References
Dastmalchi LN, Gulati M, Thurston RC, Lau E, Sarma A, Marfori CQ, et al. Improving Cardiovascular Clinical Competencies for the Menopausal Transition: A Focus on Cardiometabolic Health in Midlife.JACC Adv. 2025;4:101791. [DOI] [PubMed] [PMC]
Ambikairajah A, Walsh E, Cherbuin N. A review of menopause nomenclature.Reprod Health. 2022;19:29. [DOI] [PubMed] [PMC]
Alemany M. Steroid hormones interrelationships in the metabolic syndrome: An introduction to the ponderostat hypothesis.Hormones (Athens). 2012;11:272–89. [DOI] [PubMed]
Alberti KGMM, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome—a new worldwide definition.Lancet. 2005;366:1059–62. [DOI] [PubMed]
Reaven GM. Role of insulin resistance in human disease.Nutrition. 1997;13:64. [DOI] [PubMed]
Kaplan NM. The Deadly Quartet. Upper-Body Obesity, Glucose Intolerance, Hypertriglyceridemia, and Hypertension.Arch Intern Med. 1989;149:1514–20. [DOI] [PubMed]
Ferrannini E. The insulin resistance syndrome.Curr Opin Nephrol Hypertens. 1992;1:291–8. [DOI] [PubMed]
Obeidat AA, Ahmad MN, Ghabashi MA, Alazzeh AY, Habib SM, Abu Al-Haijaa D, et al. Developmental Trends of Metabolic Syndrome in the Past Two Decades: A Narrative Review.J Clin Med. 2025;14:2402. [DOI] [PubMed] [PMC]
Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation.Diabet Med. 1998;15:539–53. [DOI] [PubMed]
Parikh RM, Mohan V. Changing definitions of metabolic syndrome.Indian J Endocrinol Metab. 2012;16:7–12. [DOI] [PubMed] [PMC]
Saely CH, Koch L, Schmid F, Marte T, Aczel S, Langer P, et al. Adult Treatment Panel III 2001 but Not International Diabetes Federation 2005 Criteria of the Metabolic Syndrome Predict Clinical Cardiovascular Events in Subjects Who Underwent Coronary Angiography.Diabetes Care. 2006;29:901–7. [DOI] [PubMed]
Wasir JS, Misra A, Vikram NK, Pandey RM, Gupta R. Comparison of definitions of the metabolic syndrome in adult Asian Indians.J Assoc Physicians India. 2008;56:158–64. [PubMed]
Zeng Q, He Y, Dong S, Zhao X, Chen Z, Song Z, et al. Optimal cut-off values of BMI, waist circumference and waist:height ratio for defining obesity in Chinese adults.Br J Nutr. 2014;112:1735–44. [DOI] [PubMed]
Theodorakis N, Nikolaou M. From Cardiovascular-Kidney-Metabolic Syndrome to Cardiovascular-Renal-Hepatic-Metabolic Syndrome: Proposing an Expanded Framework.Biomolecules. 2025;15:213. [DOI] [PubMed] [PMC]
Neeland IJ, Lim S, Tchernof A, Gastaldelli A, Rangaswami J, Ndumele CE, et al. Metabolic syndrome.Nat Rev Dis Primers. 2024;10:77. [DOI] [PubMed]
Carr MC. The Emergence of the Metabolic Syndrome with Menopause.J Clin Endocrinol Metab. 2003;88:2404–11. [DOI] [PubMed]
Wang M, Gan W, Kartsonaki C, Guo Y, Lv J, Chen Z, et al. Menopausal status, age at natural menopause and risk of diabetes in China: a 10-year prospective study of 300,000 women.Nutr Metab (Lond). 2022;19:7. [DOI] [PubMed] [PMC]
van Dijk GM, Kavousi M, Troup J, Franco OH. Health issues for menopausal women: The top 11 conditions have common solutions.Maturitas. 2015;80:24–30. [DOI] [PubMed]
Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics—2011 Update: A Report From the American Heart Association.Circulation. 2011;123:e18–209. [DOI] [PubMed] [PMC]
Mehta LS, Velarde GP, Lewey J, Sharma G, Bond RM, Navas-Acien A, et al.; American Heart Association Cardiovascular Disease and Stroke in Women and Underrepresented Populations Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing, Council on Hypertension, Council on Lifelong Congenital Heart Disease and Heart Health in the Young, Council on Lifestyle and Cardiometabolic Health, Council on Peripheral Vascular Disease, and Stroke Council. Cardiovascular Disease Risk Factors in Women: The Impact of Race and Ethnicity: A Scientific Statement From the American Heart Association.Circulation. 2023;147:1471–87. [DOI] [PubMed] [PMC]
Hetherington K, Thomas J, Nicholls SJ, Barsha G, Bubb KJ. Unique cardiometabolic factors in women that contribute to modified cardiovascular disease risk.Eur J Pharmacol. 2024;984:177031. [DOI] [PubMed]
Zhernakova DV, Sinha T, Andreu-Sánchez S, Prins JR, Kurilshikov A, Balder J, et al.; Lifelines Cohort Study; Franke L, Kuivenhoven JA, Zhernakova A, Fu J. Age-dependent sex differences in cardiometabolic risk factors.Nat Cardiovasc Res. 2022;1:844–54. [DOI] [PubMed] [PMC]
Meloni A, Cadeddu C, Cugusi L, Donataccio MP, Deidda M, Sciomer S, et al. Gender Differences and Cardiometabolic Risk: The Importance of the Risk Factors.Int J Mol Sci. 2023;24:1588. [DOI] [PubMed] [PMC]
Ciarambino T, Crispino P, Guarisco G, Giordano M. Gender Differences in Insulin Resistance: New Knowledge and Perspectives.Curr Issues Mol Biol. 2023;45:7845–61. [DOI] [PubMed] [PMC]
Bentley-Lewis R, Koruda K, Seely EW. The metabolic syndrome in women.Nat Clin Pract Endocrinol Metab. 2007;3:696–704. [DOI] [PubMed] [PMC]
Kim HM, Park J, Ryu SY, Kim J. The Effect of Menopause on the Metabolic Syndrome Among Korean Women: The Korean National Health and Nutrition Examination Survey, 2001.Diabetes Care. 2007;30:701–6. [DOI] [PubMed]
Ebtekar F, Dalvand S, Gheshlagh RG. The prevalence of metabolic syndrome in postmenopausal women: A systematic review and meta-analysis in Iran.Diabetes Metab Syndr. 2018;12:955–60. [DOI] [PubMed]
Gurka MJ, Vishnu A, Santen RJ, DeBoer MD. Progression of Metabolic Syndrome Severity During the Menopausal Transition.J Am Heart Assoc. 2016;5:e003609. [DOI] [PubMed] [PMC]
Olejarz M, Szczepanek-Parulska E, Ruchala M. Lipoprotein alterations in endocrine disorders—a review of the recent developments in the field.Front Endocrinol (Lausanne). 2024;15:1354098. [DOI] [PubMed] [PMC]
Gonçalves VBS, Lima SMRR. Menopause and metabolic syndrome: anthropometric, lipid, and dietary profiles.Rev Assoc Med Bras (1992). 2024;70:e20231571. [DOI] [PubMed] [PMC]
Jaballah A, Soltani I, Bahia W, Dandana A, Hasni Y, Miled A, et al. The Relationship Between Menopause and Metabolic Syndrome: Experimental and Bioinformatics Analysis.Biochem Genet. 2021;59:1558–81. [DOI] [PubMed]
Cho GJ, Lee JH, Park HT, Shin JH, Hong SC, Kim T, et al. Postmenopausal status according to years since menopause as an independent risk factor for the metabolic syndrome.Menopause. 2008;15:524–9. [DOI] [PubMed]
Erdoğan K, Sanlier N. Metabolic Syndrome and Menopause: The Impact of Menopause Duration on Risk Factors and Components.Int J Womens Health. 2024;16:1249–56. [DOI] [PubMed] [PMC]
Ntikoudi A, Spyrou A, Evangelou E, Dokoutsidou E, Mastorakos G. The Effect of Menopausal Status, Insulin Resistance and Body Mass Index on the Prevalence of Non-Alcoholic Fatty Liver Disease.Healthcare (Basel). 2024;12:1081. [DOI] [PubMed] [PMC]
Kamada Y, Kiso S, Yoshida Y, Chatani N, Kizu T, Hamano M, et al. Estrogen deficiency worsens steatohepatitis in mice fed high-fat and high-cholesterol diet.Am J Physiol Gastrointest Liver Physiol. 2011;301:G1031–43. [DOI] [PubMed]
Kamada Y, Kiso S, Yoshida Y, Chatani N, Kizu T, Hamano M, et al. Pitavastatin ameliorated the progression of steatohepatitis in ovariectomized mice fed a high fat and high cholesterol diet.Hepatol Res. 2013;43:401–12. [DOI] [PubMed]
Okada Y, Yamaguchi K, Nakajima T, Nishikawa T, Jo M, Mitsumoto Y, et al. Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats.Liver Int. 2013;33:301–11. [DOI] [PubMed]
Wang PX, Deng XR, Zhang CH, Yuan HJ. Gut microbiota and metabolic syndrome.Chin Med J (Engl). 2020;133:808–16. [DOI] [PubMed] [PMC]
Yoon K, Kim N. Roles of Sex Hormones and Gender in the Gut Microbiota.J Neurogastroenterol Motil. 2021;27:314–25. [DOI] [PubMed] [PMC]
Prayag AS, Münch M, Aeschbach D, Chellappa SL, Gronfier C. Light Modulation of Human Clocks, Wake, and Sleep.Clocks Sleep. 2019;1:193–208. [DOI] [PubMed] [PMC]
Broussard JL, Van Cauter E. Disturbances of sleep and circadian rhythms: novel risk factors for obesity.Curr Opin Endocrinol Diabetes Obes. 2016;23:353–9. [DOI] [PubMed] [PMC]
Perger E, Silvestri R, Bonanni E, Di Perri MC, Fernandes M, Provini F, et al. Gender medicine and sleep disorders: from basic science to clinical research.Front Neurol. 2024;15:1392489. [DOI] [PubMed] [PMC]
Stevenson JC, Collins P, Hamoda H, Lambrinoudaki I, Maas AHEM, Maclaran K, et al. Cardiometabolic health in premature ovarian insufficiency.Climacteric. 2021;24:474–80. [DOI] [PubMed]
Federici S, Rossetti R, Moleri S, Munari EV, Frixou M, Bonomi M, et al. Primary ovarian insufficiency: update on clinical and genetic findings.Front Endocrinol (Lausanne). 2024;15:1464803. [DOI] [PubMed] [PMC]
Honigberg MC, Zekavat SM, Aragam K, Finneran P, Klarin D, Bhatt DL, et al. Association of Premature Natural and Surgical Menopause With Incident Cardiovascular Disease.JAMA. 2019;322:2411–21. [DOI] [PubMed] [PMC]
Upton CE, Daniels JP, Davies MC. Premature ovarian insufficiency: the need for evidence on the effectiveness of hormonal therapy.Climacteric. 2021;24:453–8. [DOI] [PubMed]
Karppinen JE, Törmäkangas T, Kujala UM, Sipilä S, Laukkanen J, Aukee P, et al. Menopause modulates the circulating metabolome: evidence from a prospective cohort study.Eur J Prev Cardiol. 2022;29:1448–59. [DOI] [PubMed]
Hyvärinen M, Juppi HK, Taskinen S, Karppinen JE, Karvinen S, Tammelin TH, et al. Metabolic health, menopause, and physical activity—a 4-year follow-up study.Int J Obes (Lond). 2022;46:544–54. [DOI] [PubMed] [PMC]
Bull FC, Al-Ansari SS, Biddle S, Borodulin K, Buman MP, Cardon G, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour.Br J Sports Med. 2020;54:1451–62. [DOI] [PubMed] [PMC]
Sridhar GR, Gumpeny L. Emerging significance of butyrylcholinesterase.World J Exp Med. 2024;14:87202. [DOI] [PubMed] [PMC]
Riederer P, Korczyn AD, Ali SS, Bajenaru O, Choi MS, Chopp M, et al. The diabetic brain and cognition.J Neural Transm (Vienna). 2017;124:1431–54. [DOI] [PubMed]
Monteiro SC, Stefanello FM, Vianna LP, Matte C, Barp J, Belló-Klein A, et al. Ovariectomy Enhances Acetylcholinesterase Activity But Does Not Alter Ganglioside Content in Cerebral Cortex of Female Adult Rats.Metab Brain Dis. 2005;20:35–44. [DOI] [PubMed]
Awanti SM, Ingin JB, Sabeer M, Patil RB, Jeevangi SR, Patil GA, et al. Serum butyrylcholinesterase and lipid profile in pre and “post-menopausal” women.Res J Pharmaceutical Biol Chem Sci. 2011;2:364–9.
Sridhar GR, Nirmala G, Apparao A, Madhavi AS, Sreelatha S, Rani JS, et al. Serum butyrylcholinesterase in type 2 diabetes mellitus: a biochemical and bioinformatics approach.Lipids Health Dis. 2005;4:18. [DOI] [PubMed] [PMC]
Cabre HE, Woolf EK, Redman LM. Precision Nutrition for Management of Cardiovascular Disease Risk during Menopause.Lifestyle Genom. 2024;17:93–101. [DOI] [PubMed] [PMC]
Tan A, Thomas RL, Campbell MD, Prior SL, Bracken RM, Churm R. Effects of exercise training on metabolic syndrome risk factors in post-menopausal women—A systematic review and meta-analysis of randomised controlled trials.Clin Nutr. 2023;42:337–51. [DOI] [PubMed]
Erdélyi A, Pálfi E, Tűű L, Nas K, Szűcs Z, Török M, et al. The Importance of Nutrition in Menopause and Perimenopause—A Review.Nutrients. 2023;16:27. [DOI] [PubMed] [PMC]
Bauset C, Martínez-Aspas A, Smith-Ballester S, García-Vigara A, Monllor-Tormos A, Kadi F, et al. Nuts and Metabolic Syndrome: Reducing the Burden of Metabolic Syndrome in Menopause.Nutrients. 2022;14:1677. [DOI] [PubMed] [PMC]
Chen LR, Chen KH. Utilization of Isoflavones in Soybeans for Women with Menopausal Syndrome: An Overview.Int J Mol Sci. 2021;22:3212. [DOI] [PubMed] [PMC]
Karimi G, Heidari Z, Firouzi S, Haghighatdoost F. A systematic review and meta-analysis of the association between fish consumption and risk of metabolic syndrome.Nutr Metab Cardiovasc Dis. 2020;30:717–29. [DOI] [PubMed]
Bobescu E, Bălan A, Moga MA, Teodorescu A, Mitrică M, Dima L. Are There Any Beneficial Effects of Spirulina Supplementation for Metabolic Syndrome Components in Postmenopausal Women?Mar Drugs. 2020;18:651. [DOI] [PubMed] [PMC]
Meegaswatte H, Speer K, McKune AJ, Naumovski N. Functional Foods and Nutraceuticals for the Management of Cardiovascular Disease Risk in Postmenopausal Women.Rev Cardiovasc Med. 2024;25:460. [DOI] [PubMed] [PMC]
Oh J, Kim M, Kim J, Jang J, Noh D, Kim HS. Effects of Cnidium officinale, Pueraria lobata Ohwi, and Leonurus japonicus Extract on Vascular Endothelial Dysfunctions in Ovariectomized Rats and Molecular Mechanisms.Int J Mol Sci. 2025;26:4708. [DOI] [PubMed] [PMC]
Li CM, Dong XL, Fan XD, Wu JH, Wang QH, Tian XL, et al. Aqueous extract of danshen (Salvia miltiorrhiza Bunge) protects ovariectomized rats fed with high-fat diet from endothelial dysfunction.Menopause. 2013;20:100–9. [DOI] [PubMed]
Abdulghani MF, Al-Fayyadh S. Natural products for managing metabolic syndrome: a scoping review.Front Pharmacol. 2024;15:1366946. [DOI] [PubMed] [PMC]
Chester RC, Kling JM, Manson JE. What the Women’s Health Initiative has taught us about menopausal hormone therapy.Clin Cardiol. 2018;41:247–52. [DOI] [PubMed] [PMC]
Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ. A Prospective, Observational Study of Postmenopausal Hormone Therapy and Primary Prevention of Cardiovascular Disease.Ann Intern Med. 2000;133:933–41. [DOI] [PubMed]
Notman MT, Nadelson C. The hormone replacement therapy controversy.Arch Womens Ment Health. 2002;5:33–5. [DOI] [PubMed]
The Women’s Health Initiative Study Group. Design of the Women’s Health Initiative clinical trial and observational study. The Women’s Health Initiative Study Group.Control Clin Trials. 1998;19:61–109. [DOI] [PubMed]
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al.; Writing Group for the Women’s Health Initiative Investigators. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women’s Health Initiative Randomized Controlled Trial.JAMA. 2002;288:321–33. [DOI] [PubMed]
Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, et al. Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women’s Health Initiative Randomized Trials.JAMA. 2013;310:1353–68. [DOI] [PubMed] [PMC]
Manson JE, Aragaki AK, Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, et al.; WHI Investigators. Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women’s Health Initiative Randomized Trials.JAMA. 2017;318:927–38. [DOI] [PubMed] [PMC]
Hodis HN, Mack WJ, Shoupe D, Azen SP, Stanczyk FZ, Hwang-Levine J, et al. Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis.Menopause. 2015;22:391–401. [DOI] [PubMed] [PMC]
Karim R, Xu W, Kono N, Sriprasert I, Li Y, Yan M, et al. Effect of menopausal hormone therapy on arterial wall echomorphology: Results from the Early versus Late Intervention Trial with Estradiol (ELITE).Maturitas. 2022;162:15–22. [DOI] [PubMed] [PMC]
Miller VM, Taylor HS, Naftolin F, Manson JE, Gleason CE, Brinton EA, et al. Lessons from KEEPS: the Kronos Early Estrogen Prevention Study.Climacteric. 2021;24:139–45. [DOI] [PubMed] [PMC]
Miller VM, Naftolin F, Asthana S, Black DM, Brinton EA, Budoff MJ, et al. The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned?Menopause. 2019;26:1071–84. [DOI] [PubMed] [PMC]
Davis SR, Baber RJ. Treating menopause—MHT and beyond.Nat Rev Endocrinol. 2022;18:490–502. [DOI] [PubMed]
Mikkola TS, Tuomikoski P, Lyytinen H, Korhonen P, Hoti F, Vattulainen P, et al. Increased Cardiovascular Mortality Risk in Women Discontinuing Postmenopausal Hormone Therapy.J Clin Endocrinol Metab. 2015;100:4588–94. [DOI] [PubMed]
Anagnostis P, Lambrinoudaki I, Stevenson JC, Goulis DG. Menopause-associated risk of cardiovascular disease.Endocr Connect. 2022;11:e210537. [DOI] [PubMed] [PMC]
